More on this book
Community
Kindle Notes & Highlights
High level officials, including Dr. Fauci, receive yearly emoluments of up to $150,000 in royalty payments on products that they help develop and then usher through the approval process.4 The FDA receives 45 percent of its budget from the pharmaceutical industry, through what are euphemistically called “user fees.”
His $417,608 annual salary makes him the highest paid of all four million federal employees, including the President.
blind faith in authority is a function of religion, not science.
CDC later admitted that only 6 percent of COVID deaths occurred in entirely healthy individuals. The remaining 94 percent suffered from an average of 3.8 potentially fatal comorbidities.24 Regulators misused PCR tests that CDC belatedly admitted in August 2021 were incapable of distinguishing COVID from other viral illnesses.
The CDC and World Health Organization, indeed all global health authorities, have recognized that healthy people, with healthy immune systems, bear minimal risk from COVID. Indeed, many people, according to our health authorities, have an immune response sufficient that they don’t even know they have COVID.
Risch, McCullough, and Kory are among the large chorus of experts (including Nobel Laureate Luc Montagnier) who argue that, by treating infected patients at home during the early stages of the illness, we could have averted cataclysmic lockdowns and found medicine resources for protecting vulnerable populations while encouraging the spread of the disease in age groups with extremely low-risk, in order to achieve permanent herd immunity. They point out that natural immunity, in all known cases, is superior to vaccine-induced immunity, being both more durable (it often lasts a lifetime) and
...more
Instead of supporting McCullough’s work, NIH and the other federal regulators began actively censoring information on this range of effective remedies. Doctors who attempted merely to open discussion about the potential benefits of early treatments for COVID found themselves heavily and inexplicably censored. Dr. Fauci worked with Facebook’s Mark Zuckerberg and other social media sites to muzzle discussion of any remedies. FDA sent a letter of warning that N-acetyle-L-cysteine (NAC) cannot be lawfully marketed as a dietary supplement, after decades of free access on health food shelves, and
...more
Cole points out that, “If you are under 70 years of age and have no severe preexisting illness, you can hardly die [from SARS-CoV-2 infection]. So, there is no fatality rate that can be reduced. . . . And for people who are elderly and have preexisting illness,” he adds, “as we know from Dr. Peter McCullough and his colleagues’ work, there are miraculously effective medicines to treat this virus so that the fatality rates go down another 70 to 80 percent, which means there is no ground for emergency use whatsoever. That’s a huge threat to the vaccine cartel and to remdesivir.”
From the outset, hydroxychloroquine (HCQ) and other therapeutics posed an existential threat to Dr. Fauci and Bill Gates’ $48 billion COVID vaccine project, and particularly to their vanity drug remdesivir, in which Gates has a large stake.1 Under federal law, new vaccines and medicines cannot quality for Emergency Use Authorization (EUA) if any existing FDA-approved drug proves effective against the same malady:
Dr. Fauci has invested $6 billion in taxpayer lucre in the Moderna vaccine alone.3 His agency is co-owner4 of the patent and stands to collect a fortune in royalties. At least four of Fauci’s hand-picked deputies are in line to collect royalties of $150,000/year based on Moderna’s success, and that’s on top of the salaries already paid by the American public.
A CDC study published in 2005 in the Virology Journal, “Chloroquine is a Potent Inhibitor of SARS Coronavirus Infection and Spread” demonstrated that CQ quickly eliminated coronavirus in primate cell culture during the SARS outbreak. That study concludes: “We report . . . that chloroquine has strong antiviral effects on SARS-Coronavirus infection of primate cells . . . [both] before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”15
HCQ’s critics—largely funded by Bill Gates and Dr. Tony Fauci31—had misinterpreted, misstated, and misreported negative results by employing faulty protocols, most of which showed HCQ efficacy administered without zinc and Zithromax which were known to be helpful. But their main trick for ensuring the protocols failed was to wait until late in the disease process before administering HCQ—when it is known to be ineffective.
Regulators do not understand the mechanism of action of many drugs, but they nonetheless license those that are effective and safe. The fact is that we know more about how HCQ beats COVID than we know about the actions of many other medicines, including—notably—Dr. Fauci’s darlings, mRNA vaccines and remdesivir.
ALL the studies on early administration of HCQ within a week following infection demonstrate efficacy, while studies of HCQ administered later in the illness show mixed results.
On January 13, when rumors of Wuhan flu COVID-19 began to circulate, the French government took the bizarre, inexplicable, unprecedented, and highly suspicious step of reassigning HCQ from an over-the-counter to a prescription medicine.43 Without citing any studies, French health officials quietly changed the status of HCQ to “List II poisonous substance” and banned its over-the-counter sales.44 This absolutely remarkable coincidence repeated itself a few weeks later when Canadian health officials did the exact same thing, quietly removing the drug from pharmacy shelves.45 A physician from
...more
On March 13, a Michigan doctor and trader, Dr. James Todaro, M.D., tweeted his review of HCQ as an effective COVID treatment, including a link to a public Google doc.48,49 Google quietly scrubbed Dr. Todaro’s memo. This was six days before the President endorsed HCQ. Google apparently didn’t want users to think Todaro’s message was missing; rather, the Big Tech platform wanted the public to believe that Todaro’s memo never even existed. Google has a long history of suppressing information that challenges vaccine industry profits. Google’s parent company Alphabet owns several vaccine companies,
...more
In March, at HHS’s request, several large pharmaceutical companies—Novartis, Bayer, Sanofi, and others—donated their inventory, a total of 63 million doses of hydroxychloroquine and 2 million of chloroquine, to the Strategic National Stockpile, managed by BARDA, an agency under the DHHS Assistant Secretary for Preparedness and Response.56 BARDA’s Director, Dr. Rick Bright, later claimed the chloroquine drugs were deadly, and he needed to protect the American public from them.57 Bright colluded with FDA to restrict use of the donated pills to hospitalized patients.
FDA took the unprecedented step of revoking HCQ’s emergency authorization,58 rendering that enormous stockpile of valuable pills off limits to Americans while conveniently indemnifying the pharmaceutical companies for their inventory losses by allowing them a tax break for the donations.
In a bit of twisted logic, Federal officials continued to encourage doctors to use the suddenly-dangerous drug without restriction for lupus, rheumatoid arthritis, Lyme and malaria. Just not for COVID.
the Moderna vaccine, in which he invested years and six billion taxpayer dollars. He was thrilled to sponsor a human trial of a Moderna COVID vaccine (partly owned by his agency), before there were any safety and efficacy data from animal studies, which goes against FDA regulations.
WHO includes IVM (along with HCQ) on its inventory of “essential medicines”—its list of remedies so necessary, safe, efficacious, and affordable that WHO deems easy access to them as essential “to satisfy the priority health care needs of the population.”2 WHO has recommended administering ivermectin to entire populations to treat people who might have parasitic infections—meaning they consider it safe enough to give to people who haven’t even been diagnosed.
Furthermore, a 2021 study suggested that a key biological mechanism of IVM— competitive binding with SARS-CoV-2 spike protein—was not specific to any coronavirus variant and therefore, unlike vaccines, ivermectin would probably be effective against all future variants.11
Ivermectin stops replication of COVID-19, seasonal flu, and many other viruses through this and other mechanisms.
A WHO-sponsored meta-review21 of 11 studies likewise suggests ivermectin can reduce COVID-19 mortality by as much as 83 percent.
Over all these studies, ivermectin protected 6 of every 7 people who used it to prevent COVID.
“COVID resulted in ~6 million hospitalizations and 700,000+ deaths in America,” says Dr. Kory. “If HCQ and IVM had been widely used instead of systematically suppressed, we could have prevented 75 percent, or at least 500,000 deaths, and 80 percent of hospitalizations, or 4.8 million. We could have spared the states hundreds of billions of dollars.”
The Desert Review reported that in April 2021, New Delhi was experiencing a COVID epidemic crisis. The state government obliterated 97 percent of Delhi cases by distributing ivermectin.41 “IVM Crushed COVID in New Delhi,” wrote Dr. Justus R. Hope, M.D.42 Following IVM’s introduction, according to TrialSite News, cases dropped dramatically.
In May-June 2020, a team at Agra [Uttar Pradesh’s fourth largest city], led by Dr. Anshul Pareek, administered ivermectin to all RRT team members in the district on an experimental basis. None of them developed Covid-19 despite being in daily contact with patients who had tested positive for the virus.48
Meanwhile, the Indian state of Tamil Nadu continued using Anthony Fauci’s protocol of administering remdesivir, outlawing ivermectin, and discouraging early treatment. According to the Indian Times, Tamil Nadu continues to experience cases and fatalities that perfectly match the US catastrophe.55
During the early industry offensive against HCQ, one of the drug’s principal manufacturers, Sanofi, suddenly detected “safety concerns” with HCQ that it had never noticed during decades of profitable pre-pandemic production. In a remarkable coincidence, on February 4, 2021, Merck similarly discovered “a concerning lack of safety data in the majority of studies” regarding IVM.71 Merck was ivermectin’s original manufacturer and had formerly boasted of ivermectin as its “wonder drug.”
But most importantly, ivermectin is also a low-profit competitor for another new Merck product for COVID-19—a high-cost antiviral drug, molnupiravir, for which Merck had the highest financial ambitions. Ironically, molnupiravir, a copycat formula, utilized an identical mechanism of action as ivermectin.74 That drug will retail at around $700 per course75 but only if Merck can kill its cheap rival.
Not only was the drug developed with taxpayer money, but its $712 per dose price to the taxpayer is forty times more than Merck’s $17.64 cost of production. Merck, which expects to make $7 billion per year on the new blockbuster, saw its stock price spike on news of the government contract and after President Biden’s televised plug.
Pfizer, was racing Merck neck and neck with its own anti-viral pill, PF-07321332,82 an ivermectin knockoff that is so similar to IVM (except, of course, in price point) that critics call it “Pfizermectin.”83
In late August 2021, NIH, FDA, and CDC launched an innovative new campaign to slander ivermectin as a “horse dewormer” that only deluded foolhardy nincompoops would consume.
Elsewhere on its website, the CDC urged black and brown human immigrants to load up on ivermectin. “All Middle Eastern, Asian, North African, Latin American, and Caribbean refugees should receive presumptive therapy with: ivermectin, two doses 200 mcg/Kg orally once a day for two days before departure to the United States.85 Whether this was intended to deworm them or to prevent COVID transmission during travel to the US is unclear.
Demonizing IVM as a “horse drug” was, of course, ironic, given that NIAID initially developed Merck’s replacement therapy, molnupiravir, as a horse drug.
It wasn’t just the safe drug and caring physicians that were under attack. When, in September 2021, the popular comedian and podcast host Joe Rogan announced he’d kicked COVID in just a few days using a cocktail of drugs, including ivermectin, the global press, government, and pharmaceutical interests coalesced to denounce, vilify, and gaslight him.
Rolling Stone also reported that Oklahomans overdosing on ivermectin horse dewormer were causing emergency rooms to be “so backed up that gunshot victims were having hard times getting” access to health facilities. An accompanying photo purported to depict a long line of ambulatory gunshot casualties seeking hospital admission to an Oklahoma emergency room already filled to capacity with dingbats poisoned by horse wormer.90
The story, of course, was fraud. Days later, Oklahoma’s Sequoyah Northeastern Health System posted a categorical denial on its website, dismissing the entire story as mere fabrication. That Rolling Stone picture of the long lines was an Associated Press stock photo from the previous January, a photo of people waiting in line to get vaccines.
As it turns out, not a single patient has been treated in Oklahoma for ivermectin overdose. Instead of retracting the article, Rolling Stone simply posted an attention-dodging “update” at the top of the article reporting the hospital’s denial.97
Peter McCullough laughs at the propaganda: “Ivermectin is a molecule that is miraculously effective against parasites and viral infections along multiple pathways and mechanisms of action. It’s a molecule. It doesn’t care if it’s used in a horse, or a cow, or a human. The rules of physics and chemistry are the same across species.”
Remdesivir has no clinical efficacy against COVID, according to every legitimate study. Worse, it is deadly poisonous, and expensive poison at $3,000 for treatment.1
Might it have something to with NIAID and CDC having just spent $79 million2 developing remdesivir for Gilead, a company in which the Bill & Melinda Gates Foundation owns a $6.5 million stake?3,4
Dr. Fauci had another NIAID-incubated drug, ZMapp, in the same clinical trial, testing efficacy against Ebola alongside two experimental monoclonal antibody drugs. Researchers planned to administer all four drugs to Ebola patients across Africa over a period of four to eight months.10,11 However, six months into the Ebola study, the trial’s Safety Review Board suddenly pulled both remdesivir and ZMapp from the trial.12 Remdesivir, it turned out, was hideously dangerous. Within 28 days, subjects taking remdesivir had lethal side effects including multiple organ failure, acute kidney failure,
...more
Remdesivir, however, was an IV remedy, appropriate only for use on hospitalized patients in the late stages of illness. It would therefore not compete with vaccines, allowing Dr. Fauci to support it without compromising his core business.
Remdesivir cost Gilead $10 per dose to manufacture.18,19 But by granting Gilead an EUA, regulators could force private insurers, Medicare, and Medicaid to fork over around $3,120.00 per treatment—hundreds of times the cost of the drug.20,21 Gilead predicted remdesivir would bring in $3.5 billion in 2020 alone.22
Dr. Fauci learned that The Lancet had just published a placebo-controlled Chinese study that showed remdesivir utterly ineffective at keeping hospitalized patients alive OR reducing the duration of hospitalizations.48 Even more importantly, remdesivir did not reduce the presence of the virus in the blood. Worst of all, the Chinese study confirmed remdesivir’s deadly toxicity.
On July 15, 2021, a large Johns Hopkins Study in Original Investigation | Infectious Diseases once again confirmed that “Remdesivir treatment was not associated with improved survival but was associated with longer hospital stays.”72
On October 2, 2020, the European Union released its own safety review of remdesivir. The study reported serious side effects.73,74
Assessing remdesivir’s impact on hospitalized COVID-19 patients is difficult, in part, because—like COVID-19—remdesivir causes extreme toxicity to lungs and kidneys,78 and mimics several of the other lethal symptoms of COVID, including multi-organ failure.79
